SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000921895-19-000132
Filing Date
2019-01-22
Accepted
2019-01-22 16:32:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13D sc13d06922010_01222019.htm SC 13D 55675
  Complete submission text file 0000921895-19-000132.txt   57053
Mailing Address 611 SOUTH FORT HARRISON AVE SUITE 306 CLEARWATER FL 33756
Business Address
DUGGAN ROBERT W (Filed by) CIK: 0001055919 (see all company filings)

Type: SC 13D

Mailing Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB
Business Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB 44-123-544-3939
Summit Therapeutics plc (Subject) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0131
Type: SC 13D | Act: 34 | File No.: 005-88759 | Film No.: 19535676
SIC: 2834 Pharmaceutical Preparations